Collaborative projects
Inserm Transfert, founded in 2000, is the private subsidiary of Inserm specialized in life sciences technology transfer and collaborative reasearch projects funding. It works under a Public Service Delegation Agreement (DSP).
INVENTS
The evaluation of new medicines for rare diseases is challenging for several reasons, among which are the small patient sample sizes, heterogeneity of patients Read more
Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)
Inflammatory bowel disease (IBD) refers to a group of chronic conditions that cause inflammation in the digestive tract. IBD requires long-term management and Read more
Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
ARTiDe aims to develop a new antigen-specific immunotherapy for type 1 diabetes, via genetic engineering, using patients' regulatory T lymphocytes (Treg) to Read more
